Fact CheckerSign in

NCT07482033Not yet recruiting

The Impact of Training on Self-Efficacy, Symptom Level, and Activities of Daily Living

The Effect of Pecha Kucha Training on Noninvasive Mechanical Ventilation Support for Individuals With Chronic Obstructive Pulmonary Disease on Self-Efficacy, Symptom Level, and Daily Living Activities

Source: ClinicalTrials.gov · Last updated 24 Apr 2026

Brief summary (registry, in English)

This study is a randomized, controlled experimental trial with a pretest-posttest design, conducted to evaluate the effects of Pecha Kucha-based education on self-efficacy, symptom level, and activities of daily living in individuals diagnosed with chronic obstructive pulmonary disease (COPD) receiving noninvasive mechanical ventilation support. The study will include two groups, and intergroup differences will be evaluated: 1. Control group 2. Intervention group Study Hypotheses H1: Pecha Kucha-based education on noninvasive mechanical ventilation (NIMV) support provided to individuals with chronic obstructive pulmonary disease (COPD) increases patients' self-efficacy levels. H2: Pecha Kucha-based education on noninvasive mechanical ventilation (NIMV) support provided to individuals with chronic obstructive pulmonary disease (COPD) reduces patients' symptom levels. H3: Pecha Kucha-based education on noninvasive mechanical ventilation (NIMV) support provided to individuals with chronic obstructive pulmonary disease (COPD) improves patients' activities of daily living.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
60 (estimated)
First submitted
6 Jan 2026
Start date
1 May 2026
Primary completion date
31 Oct 2026
Lead sponsor
Istanbul Saglik Bilimleri University
Diseases
COPD
NCT number
NCT07482033

What you commit to

  • Study type: Interventional
  • Planned participants: 60
  • From 1 May 2026 to the primary completion date, 31 Oct 2026
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Failure to attend planned educational sessions or inability to complete the study protocol
  • Development of a serious health condition preventing continuation in the education program (e.g., hospitalization, acute exacerbation, deterioration in mental status)

Other

  • Voluntary withdrawal from the study, declared verbally or in writing
  • Death during the study period
  • Loss of phone or internet access preventing receipt of educational materials
  • Significant communication problems that substantially interfere with participation in the educational process

Who the study is looking for

  • Age 18 years or older
  • Diagnosed with chronic obstructive pulmonary disease (COPD) at least one year prior
  • Currently receiving treatment with noninvasive mechanical ventilation (NIMV) support
  • Ability to communicate verbally and in writing in a clear and sustainable manner
  • No severe visual or hearing impairment that would prevent understanding of educational materials
  • Basic ability to use a smartphone
  • Active use of the WhatsApp application on a personal smartphone
  • Technical capability to view educational materials sent via phone (e.g., internet access, video playback)
  • No prior education on NIMV delivered using the Pecha Kucha presentation technique
  • Adequate cognitive function to allow independent participation (e.g., no history of dementia or confusion)
  • Availability to attend educational and assessment sessions as scheduled

Age in the registry: 18 days to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.